Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1953 1
1961 1
1962 1
1963 1
1989 1
1991 1
1995 1
1996 1
1997 2
1998 1
1999 2
2001 3
2002 3
2003 3
2004 3
2005 4
2006 6
2007 14
2008 12
2009 9
2010 11
2011 9
2012 11
2013 12
2014 16
2015 13
2016 16
2017 20
2018 19
2019 15
2020 17
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Results by year
Filters applied: . Clear all
Page 1
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Rayego-Mateos S, et al. Among authors: mas s. Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798. Int J Mol Sci. 2020. PMID: 32471207 Free PMC article. Review.
Targeting inflammation in diabetic nephropathy: a tale of hope.
Moreno JA, Gomez-Guerrero C, Mas S, Sanz AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S, Egido J. Moreno JA, et al. Among authors: mas s. Expert Opin Investig Drugs. 2018 Nov;27(11):917-930. doi: 10.1080/13543784.2018.1538352. Epub 2018 Oct 23. Expert Opin Investig Drugs. 2018. PMID: 30334635 Review.
Animal models of cardiovascular diseases.
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Zaragoza C, et al. Among authors: mas s. J Biomed Biotechnol. 2011;2011:497841. doi: 10.1155/2011/497841. Epub 2011 Feb 16. J Biomed Biotechnol. 2011. PMID: 21403831 Free PMC article. Review.
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.
González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A; DiabetesCancerConnect Consortium. González N, et al. Among authors: mas s. Oncotarget. 2017 Mar 14;8(11):18456-18485. doi: 10.18632/oncotarget.14472. Oncotarget. 2017. PMID: 28060743 Free PMC article. Review.
Protective Role of Nrf2 in Renal Disease.
Guerrero-Hue M, Rayego-Mateos S, Vázquez-Carballo C, Palomino-Antolín A, García-Caballero C, Opazo-Rios L, Morgado-Pascual JL, Herencia C, Mas S, Ortiz A, Rubio-Navarro A, Egea J, Villalba JM, Egido J, Moreno JA. Guerrero-Hue M, et al. Among authors: mas s. Antioxidants (Basel). 2020 Dec 31;10(1):39. doi: 10.3390/antiox10010039. Antioxidants (Basel). 2020. PMID: 33396350 Free PMC article. Review.
Proteomics in atherosclerosis.
Martinez-Pinna R, Martin-Ventura JL, Mas S, Blanco-Colio LM, Tuñon J, Egido J. Martinez-Pinna R, et al. Among authors: mas s. Curr Atheroscler Rep. 2008 Jun;10(3):209-15. doi: 10.1007/s11883-008-0033-z. Curr Atheroscler Rep. 2008. PMID: 18489848 Review.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Among authors: mas s. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
211 results